Clinical Trials Directory

Trials / Unknown

UnknownNCT06137209

Colonization of Skin by M. Luteus Q24 Probiotic

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Serum in Healthy Adults

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
BLIS Technologies Limited · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the face from a serum format in healthy adults.

Detailed description

This is a randomized double-blind baseline controlled pilot study with no crossover for the assessment of any changes to the microbial make-up of the skin (The local skin microbiome), detection of colonization by the probiotic bacterium (BLIS Q24) on the skin and to evaluate the changes in skin quality parameters following topical application of probiotic in a serum format.

Conditions

Interventions

TypeNameDescription
OTHERActive Comparator: Study Group A: Blis Q24 Serum at higher doseActive Comparator: Study Group A: Blis Q24 Serum at 1e7 cfu/ dose (Active)
OTHERActive Comparator: Study Group B: Blis Q24 Serum at lower doseActive Comparator: Study Group B: Blis Q24 Serum at 1e6 cfu/ dose (Active)

Timeline

Start date
2023-10-02
Primary completion
2023-11-22
Completion
2024-03-15
First posted
2023-11-18
Last updated
2023-11-18

Locations

1 site across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT06137209. Inclusion in this directory is not an endorsement.